Global Friedreich Ataxia Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Friedreich Ataxia Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Friedreich Ataxia Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Friedreich Ataxia Drug by Country/Region, 2017, 2022 & 2028

2.2 Friedreich Ataxia Drug Segment by Type

2.2.1 ADVM-063

2.2.2 AGIL-FA

2.2.3 BHV-4157

2.2.4 BVA-202

2.2.5 Others

2.3 Friedreich Ataxia Drug Sales by Type

2.3.1 Global Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Friedreich Ataxia Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Friedreich Ataxia Drug Sale Price by Type (2017-2022)

2.4 Friedreich Ataxia Drug Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Friedreich Ataxia Drug Sales by Application

2.5.1 Global Friedreich Ataxia Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Friedreich Ataxia Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Friedreich Ataxia Drug Sale Price by Application (2017-2022)

3 Global Friedreich Ataxia Drug by Company

3.1 Global Friedreich Ataxia Drug Breakdown Data by Company

3.1.1 Global Friedreich Ataxia Drug Annual Sales by Company (2020-2022)

3.1.2 Global Friedreich Ataxia Drug Sales Market Share by Company (2020-2022)

3.2 Global Friedreich Ataxia Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Friedreich Ataxia Drug Revenue by Company (2020-2022)

3.2.2 Global Friedreich Ataxia Drug Revenue Market Share by Company (2020-2022)

3.3 Global Friedreich Ataxia Drug Sale Price by Company

3.4 Key Manufacturers Friedreich Ataxia Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Friedreich Ataxia Drug Product Location Distribution

3.4.2 Players Friedreich Ataxia Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Friedreich Ataxia Drug by Geographic Region

4.1 World Historic Friedreich Ataxia Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Friedreich Ataxia Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Friedreich Ataxia Drug Annual Revenue by Geographic Region

4.2 World Historic Friedreich Ataxia Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Friedreich Ataxia Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Friedreich Ataxia Drug Annual Revenue by Country/Region

4.3 Americas Friedreich Ataxia Drug Sales Growth

4.4 APAC Friedreich Ataxia Drug Sales Growth

4.5 Europe Friedreich Ataxia Drug Sales Growth

4.6 Middle East & Africa Friedreich Ataxia Drug Sales Growth

5 Americas

5.1 Americas Friedreich Ataxia Drug Sales by Country

5.1.1 Americas Friedreich Ataxia Drug Sales by Country (2017-2022)

5.1.2 Americas Friedreich Ataxia Drug Revenue by Country (2017-2022)

5.2 Americas Friedreich Ataxia Drug Sales by Type

5.3 Americas Friedreich Ataxia Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Friedreich Ataxia Drug Sales by Region

6.1.1 APAC Friedreich Ataxia Drug Sales by Region (2017-2022)

6.1.2 APAC Friedreich Ataxia Drug Revenue by Region (2017-2022)

6.2 APAC Friedreich Ataxia Drug Sales by Type

6.3 APAC Friedreich Ataxia Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Friedreich Ataxia Drug by Country

7.1.1 Europe Friedreich Ataxia Drug Sales by Country (2017-2022)

7.1.2 Europe Friedreich Ataxia Drug Revenue by Country (2017-2022)

7.2 Europe Friedreich Ataxia Drug Sales by Type

7.3 Europe Friedreich Ataxia Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Friedreich Ataxia Drug by Country

8.1.1 Middle East & Africa Friedreich Ataxia Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Friedreich Ataxia Drug Sales by Type

8.3 Middle East & Africa Friedreich Ataxia Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Friedreich Ataxia Drug

10.3 Manufacturing Process Analysis of Friedreich Ataxia Drug

10.4 Industry Chain Structure of Friedreich Ataxia Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Friedreich Ataxia Drug Distributors

11.3 Friedreich Ataxia Drug Customer

12 World Forecast Review for Friedreich Ataxia Drug by Geographic Region

12.1 Global Friedreich Ataxia Drug Market Size Forecast by Region

12.1.1 Global Friedreich Ataxia Drug Forecast by Region (2023-2028)

12.1.2 Global Friedreich Ataxia Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Friedreich Ataxia Drug Forecast by Type

12.7 Global Friedreich Ataxia Drug Forecast by Application

13 Key Players Analysis

13.1 Adverum Biotechnologies Inc

13.1.1 Adverum Biotechnologies Inc Company Information

13.1.2 Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Offered

13.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Adverum Biotechnologies Inc Main Business Overview

13.1.5 Adverum Biotechnologies Inc Latest Developments

13.2 BioMarin Pharmaceutical Inc.

13.2.1 BioMarin Pharmaceutical Inc. Company Information

13.2.2 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Offered

13.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BioMarin Pharmaceutical Inc. Main Business Overview

13.2.5 BioMarin Pharmaceutical Inc. Latest Developments

13.3 Biovista Inc.

13.3.1 Biovista Inc. Company Information

13.3.2 Biovista Inc. Friedreich Ataxia Drug Product Offered

13.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biovista Inc. Main Business Overview

13.3.5 Biovista Inc. Latest Developments

13.4 Cardero Therapeutics Inc

13.4.1 Cardero Therapeutics Inc Company Information

13.4.2 Cardero Therapeutics Inc Friedreich Ataxia Drug Product Offered

13.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cardero Therapeutics Inc Main Business Overview

13.4.5 Cardero Therapeutics Inc Latest Developments

13.5 Catabasis Pharmaceuticals, Inc.

13.5.1 Catabasis Pharmaceuticals, Inc. Company Information

13.5.2 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Offered

13.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Catabasis Pharmaceuticals, Inc. Main Business Overview

13.5.5 Catabasis Pharmaceuticals, Inc. Latest Developments

13.6 Forward Pharma A/S

13.6.1 Forward Pharma A/S Company Information

13.6.2 Forward Pharma A/S Friedreich Ataxia Drug Product Offered

13.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Forward Pharma A/S Main Business Overview

13.6.5 Forward Pharma A/S Latest Developments

13.7 Ixchel Pharma LLC

13.7.1 Ixchel Pharma LLC Company Information

13.7.2 Ixchel Pharma LLC Friedreich Ataxia Drug Product Offered

13.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ixchel Pharma LLC Main Business Overview

13.7.5 Ixchel Pharma LLC Latest Developments

13.8 Pfizer Inc

13.8.1 Pfizer Inc Company Information

13.8.2 Pfizer Inc Friedreich Ataxia Drug Product Offered

13.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pfizer Inc Main Business Overview

13.8.5 Pfizer Inc Latest Developments

13.9 ProQR Therapeutics NV

13.9.1 ProQR Therapeutics NV Company Information

13.9.2 ProQR Therapeutics NV Friedreich Ataxia Drug Product Offered

13.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ProQR Therapeutics NV Main Business Overview

13.9.5 ProQR Therapeutics NV Latest Developments

13.10 RaNA Therapeutics Inc

13.10.1 RaNA Therapeutics Inc Company Information

13.10.2 RaNA Therapeutics Inc Friedreich Ataxia Drug Product Offered

13.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 RaNA Therapeutics Inc Main Business Overview

13.10.5 RaNA Therapeutics Inc Latest Developments

13.11 Reata Pharmaceuticals Inc

13.11.1 Reata Pharmaceuticals Inc Company Information

13.11.2 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Offered

13.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Reata Pharmaceuticals Inc Main Business Overview

13.11.5 Reata Pharmaceuticals Inc Latest Developments

13.12 Retrotope Inc

13.12.1 Retrotope Inc Company Information

13.12.2 Retrotope Inc Friedreich Ataxia Drug Product Offered

13.12.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Retrotope Inc Main Business Overview

13.12.5 Retrotope Inc Latest Developments

13.13 Takeda

13.13.1 Takeda Company Information

13.13.2 Takeda Friedreich Ataxia Drug Product Offered

13.13.3 Takeda Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Takeda Main Business Overview

13.13.5 Takeda Latest Developments

13.14 STATegics Inc

13.14.1 STATegics Inc Company Information

13.14.2 STATegics Inc Friedreich Ataxia Drug Product Offered

13.14.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 STATegics Inc Main Business Overview

13.14.5 STATegics Inc Latest Developments

13.15 Voyager Therapeutics Inc

13.15.1 Voyager Therapeutics Inc Company Information

13.15.2 Voyager Therapeutics Inc Friedreich Ataxia Drug Product Offered

13.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Voyager Therapeutics Inc Main Business Overview

13.15.5 Voyager Therapeutics Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Friedreich Ataxia Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Friedreich Ataxia Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of ADVM-063

Table 4. Major Players of AGIL-FA

Table 5. Major Players of BHV-4157

Table 6. Major Players of BVA-202

Table 7. Major Players of Others

Table 8. Global Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)

Table 10. Global Friedreich Ataxia Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Friedreich Ataxia Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Friedreich Ataxia Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)

Table 15. Global Friedreich Ataxia Drug Revenue by Application (2017-2022)

Table 16. Global Friedreich Ataxia Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Friedreich Ataxia Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Friedreich Ataxia Drug Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Friedreich Ataxia Drug Sales Market Share by Company (2020-2022)

Table 20. Global Friedreich Ataxia Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Friedreich Ataxia Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Friedreich Ataxia Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Friedreich Ataxia Drug Producing Area Distribution and Sales Area

Table 24. Players Friedreich Ataxia Drug Products Offered

Table 25. Friedreich Ataxia Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Friedreich Ataxia Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Friedreich Ataxia Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Friedreich Ataxia Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Friedreich Ataxia Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Friedreich Ataxia Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Friedreich Ataxia Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Friedreich Ataxia Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Friedreich Ataxia Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Friedreich Ataxia Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Friedreich Ataxia Drug Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Friedreich Ataxia Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Friedreich Ataxia Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Friedreich Ataxia Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Friedreich Ataxia Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Friedreich Ataxia Drug

Table 69. Key Market Challenges & Risks of Friedreich Ataxia Drug

Table 70. Key Industry Trends of Friedreich Ataxia Drug

Table 71. Friedreich Ataxia Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Friedreich Ataxia Drug Distributors List

Table 74. Friedreich Ataxia Drug Customer List

Table 75. Global Friedreich Ataxia Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Friedreich Ataxia Drug Sales Market Forecast by Region

Table 77. Global Friedreich Ataxia Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Friedreich Ataxia Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Friedreich Ataxia Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Friedreich Ataxia Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Friedreich Ataxia Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Friedreich Ataxia Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Friedreich Ataxia Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Friedreich Ataxia Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Friedreich Ataxia Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Friedreich Ataxia Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Friedreich Ataxia Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Friedreich Ataxia Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Friedreich Ataxia Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Friedreich Ataxia Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Friedreich Ataxia Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. Adverum Biotechnologies Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Offered

Table 97. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Adverum Biotechnologies Inc Main Business

Table 99. Adverum Biotechnologies Inc Latest Developments

Table 100. BioMarin Pharmaceutical Inc. Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Offered

Table 102. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. BioMarin Pharmaceutical Inc. Main Business

Table 104. BioMarin Pharmaceutical Inc. Latest Developments

Table 105. Biovista Inc. Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Biovista Inc. Friedreich Ataxia Drug Product Offered

Table 107. Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Biovista Inc. Main Business

Table 109. Biovista Inc. Latest Developments

Table 110. Cardero Therapeutics Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Cardero Therapeutics Inc Friedreich Ataxia Drug Product Offered

Table 112. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Cardero Therapeutics Inc Main Business

Table 114. Cardero Therapeutics Inc Latest Developments

Table 115. Catabasis Pharmaceuticals, Inc. Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Offered

Table 117. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Catabasis Pharmaceuticals, Inc. Main Business

Table 119. Catabasis Pharmaceuticals, Inc. Latest Developments

Table 120. Forward Pharma A/S Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Forward Pharma A/S Friedreich Ataxia Drug Product Offered

Table 122. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Forward Pharma A/S Main Business

Table 124. Forward Pharma A/S Latest Developments

Table 125. Ixchel Pharma LLC Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Ixchel Pharma LLC Friedreich Ataxia Drug Product Offered

Table 127. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Ixchel Pharma LLC Main Business

Table 129. Ixchel Pharma LLC Latest Developments

Table 130. Pfizer Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. Pfizer Inc Friedreich Ataxia Drug Product Offered

Table 132. Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Pfizer Inc Main Business

Table 134. Pfizer Inc Latest Developments

Table 135. ProQR Therapeutics NV Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. ProQR Therapeutics NV Friedreich Ataxia Drug Product Offered

Table 137. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. ProQR Therapeutics NV Main Business

Table 139. ProQR Therapeutics NV Latest Developments

Table 140. RaNA Therapeutics Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. RaNA Therapeutics Inc Friedreich Ataxia Drug Product Offered

Table 142. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. RaNA Therapeutics Inc Main Business

Table 144. RaNA Therapeutics Inc Latest Developments

Table 145. Reata Pharmaceuticals Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Offered

Table 147. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Reata Pharmaceuticals Inc Main Business

Table 149. Reata Pharmaceuticals Inc Latest Developments

Table 150. Retrotope Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 151. Retrotope Inc Friedreich Ataxia Drug Product Offered

Table 152. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Retrotope Inc Main Business

Table 154. Retrotope Inc Latest Developments

Table 155. Takeda Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 156. Takeda Friedreich Ataxia Drug Product Offered

Table 157. Takeda Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Takeda Main Business

Table 159. Takeda Latest Developments

Table 160. STATegics Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 161. STATegics Inc Friedreich Ataxia Drug Product Offered

Table 162. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. STATegics Inc Main Business

Table 164. STATegics Inc Latest Developments

Table 165. Voyager Therapeutics Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors

Table 166. Voyager Therapeutics Inc Friedreich Ataxia Drug Product Offered

Table 167. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. Voyager Therapeutics Inc Main Business

Table 169. Voyager Therapeutics Inc Latest Developments

List of Figures

Figure 1. Picture of Friedreich Ataxia Drug

Figure 2. Friedreich Ataxia Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Friedreich Ataxia Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Friedreich Ataxia Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Friedreich Ataxia Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of ADVM-063

Figure 10. Product Picture of AGIL-FA

Figure 11. Product Picture of BHV-4157

Figure 12. Product Picture of BVA-202

Figure 13. Product Picture of Others

Figure 14. Global Friedreich Ataxia Drug Sales Market Share by Type in 2021

Figure 15. Global Friedreich Ataxia Drug Revenue Market Share by Type (2017-2022)

Figure 16. Friedreich Ataxia Drug Consumed in Clinic

Figure 17. Global Friedreich Ataxia Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Friedreich Ataxia Drug Consumed in Hospital

Figure 19. Global Friedreich Ataxia Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 20. Friedreich Ataxia Drug Consumed in Others

Figure 21. Global Friedreich Ataxia Drug Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Friedreich Ataxia Drug Revenue Market Share by Application in 2021

Figure 24. Friedreich Ataxia Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Friedreich Ataxia Drug Revenue Market Share by Company in 2021

Figure 26. Global Friedreich Ataxia Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Friedreich Ataxia Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Friedreich Ataxia Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Friedreich Ataxia Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Friedreich Ataxia Drug Sales 2017-2022 (K Pcs)

Figure 31. Americas Friedreich Ataxia Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Friedreich Ataxia Drug Sales 2017-2022 (K Pcs)

Figure 33. APAC Friedreich Ataxia Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Friedreich Ataxia Drug Sales 2017-2022 (K Pcs)

Figure 35. Europe Friedreich Ataxia Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Friedreich Ataxia Drug Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Friedreich Ataxia Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Friedreich Ataxia Drug Sales Market Share by Country in 2021

Figure 39. Americas Friedreich Ataxia Drug Revenue Market Share by Country in 2021

Figure 40. United States Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Friedreich Ataxia Drug Sales Market Share by Region in 2021

Figure 45. APAC Friedreich Ataxia Drug Revenue Market Share by Regions in 2021

Figure 46. China Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Friedreich Ataxia Drug Sales Market Share by Country in 2021

Figure 53. Europe Friedreich Ataxia Drug Revenue Market Share by Country in 2021

Figure 54. Germany Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Friedreich Ataxia Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Friedreich Ataxia Drug in 2021

Figure 67. Manufacturing Process Analysis of Friedreich Ataxia Drug

Figure 68. Industry Chain Structure of Friedreich Ataxia Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles